The emergence and global spread of carbapenemase-producing organisms (CPO) is of great concern to health services worldwide
These bacteria are often resistant to all beta-lactam antibiotics and frequently co-resistant to most other antibiotics, leaving very few treatment options
Healthcare facilities need the ability to test high-risk patients and get an accurate result quickly during or prior to the admission process for better patient and bed management
Traditional enriched culture methods are laborious, taking up to 72 hours for a result
To address this infection control challenge, it is desirable to have a rapid, accurate, and easy to use on-demand PCR test
A comprehensive test that detects and differentiates the most prevalent carbapenemases gene families (KPC, NDM, VIM, IMP-1 and OXA-48, now covering OXA-181 and OXA- 232) is important for a successful infection control program
The Solution
Xpert Carba-R is an on-demand PCR test that detects and differentiates the most prevalent carbapenemases gene families (KPC, NDM, VIM, IMP-1 and OXA-48, now covering OXA-181 & OXA-232) in 48 minutes
Xpert Carba-R provides rapid and accurate detection of CPO; giving you actionable information to help prevent outbreaks and help determine the best patient management pathway
Enhance your infection control program with Xpert Carba-R by identifying patients that are colonized with CPO quickly
Xpert Carba-R identifies the specific genes that code for carbapenemase production that common culture methods alone cannot provide. Even sophisticated culture methods would not reveal these results in a time frame that allows effective infection control interventions
Xpert Carba-R delivers the best tool for surveillance, monitoring, and control of CPOs
The Impact
Xpert Carba-R is a critical tool: Xpert Carba-R is a much-needed tool for rapid and accurate detection of patients colonized with multidrug resistant organisms to help prevent widespread outbreaks and determine the best infection prevention pathways. for rapid and accurate detection of patients colonized with multidrug resistant organisms to help prevent outbreaks and determine the best infection prevention pathways.
For active screening of patients transferred across borders and between healthcare facilities
For active screening of high risk patients: from long-term care facilities, in transplant units, surgery and ICUs Impact on Patient Pathway
Related Products
Xpert Norovirus
Fast and accurate identification of Norovirus GI & GII in as little as one hour* *With early assay termination for positive results. Reporting negative results in 90 minutes.
Learn more
Xpert MRSA/SA SSTI
Detect MRSA & SA Skin and Soft Tissue Infections In About One Hour
Learn more
Xpert C. difficile/Epi
45-minute detection of toxigenic Clostridioides difficile and presumptive identification of 027/NAP1/BI strains
Learn more
Xpert MRSA/SA Blood Culture
Accurate detection of MRSA and SA in positive blood culture specimens in about an hour
Learn more
Xpert C. difficile
Detection of toxigenic Clostridioides difficile in 43 minutes